{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:37:48Z","timestamp":1790854668445,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dsx.2026.103374","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:26:27Z","timestamp":1769214387000},"page":"103374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of alpha lipoic acid supplementation on biochemical, clinical, and inflammatory parameters in patients with diabetic polyneuropathy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"20","author":[{"given":"Ayline Vergara","family":"Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad Meneses","family":"Caroca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Pe\u00f1a","family":"Santib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera Rojo","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"L\u00f3pez-Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Barahona-V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Paola","family":"Loaiza-Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"G\u00f3mez-Valdovinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Valenzuela-Fuenzalida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Nova-Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Orellana-Donoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Bruna-Mejias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Cifuentes-Suazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Oyanedel-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sanchis-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guinevere","family":"Granite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Araya-Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2026.103374_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","article-title":"Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition","volume":"23","author":"Bielka","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dsx.2026.103374_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2026.103374_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.dsx.2026.103374_bib4","first-page":"151","article-title":"Treating diabetic peripheral neuropathic pain","volume":"82","author":"Lindsay","year":"2010","journal-title":"Am Fam Physician"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2026.103374_bib5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/pm\/pnz075","article-title":"A comprehensive algorithm for management of neuropathic pain","volume":"20","author":"Bates","year":"2019","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.dsx.2026.103374_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diaclin.23.1.9","article-title":"Management of diabetic peripheral neuropathy","volume":"23","author":"Boulton","year":"2005","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.dsx.2026.103374_bib7","series-title":"StatPearls [Internet]. Treasure island (FL)","article-title":"Alpha-Lipoic acid","author":"Nguyen","year":"2024"},{"issue":"10","key":"10.1016\/j.dsx.2026.103374_bib8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/antiox13101228","article-title":"Alpha-Lipoic acid: biological mechanisms and health benefits","volume":"13","author":"Superti","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"16","key":"10.1016\/j.dsx.2026.103374_bib9","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3390\/nu15163634","article-title":"Effects of oral alpha-lipoic acid treatment on diabetic polyneuropathy: a meta-analysis and systematic review","volume":"15","author":"Hsieh","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.dsx.2026.103374_bib10","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.dsx.2026.103374_bib11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jrsm.1499","article-title":"Enhanced access to recommendations from the Cochrane handbook for improving authors' judgments about risk of bias: a randomized controlled trial","volume":"12","author":"Barcot","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.dsx.2026.103374_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.dsx.2026.103374_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2337\/diacare.26.3.770","article-title":"The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial","volume":"26","author":"Ametov","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2026.103374_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112308","article-title":"Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: a monocentric, randomized, double-blind, placebo-controlled clinical trial","volume":"144","author":"Esposito","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.dsx.2026.103374_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1056-8727(03)00033-3","article-title":"Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients","volume":"18","author":"Hahm","year":"2004","journal-title":"J Diabet Complicat"},{"issue":"11","key":"10.1016\/j.dsx.2026.103374_bib16","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/nu12113254","article-title":"Efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, and carnitine for 12 months in patients with diabetic neuropathy","volume":"12","author":"Didangelos","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.dsx.2026.103374_bib17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1046\/j.1464-5491.1999.00190.x","article-title":"Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy","volume":"16","author":"Ruhnau","year":"1999","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.dsx.2026.103374_bib18","article-title":"A study to evaluate the effect of alpha-lipoic acid on neuropathic symptoms in diabetic neuropathy patients on Gabapentin or Pregabalin","volume":"16","author":"Pingali","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.dsx.2026.103374_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10715769900300721","article-title":"Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic acid in diabetic neuropathy","volume":"31","author":"Reljanovic","year":"1999","journal-title":"Free Radic Res"},{"key":"10.1016\/j.dsx.2026.103374_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/189857","article-title":"Treatment with \u03b1-Lipoic acid over 16 weeks in type 2 diabetic patients with symptomatic polyneuropathy who responded to initial 4-Week high-dose loading","volume":"2015","author":"Garcia-Alcala","year":"2015","journal-title":"J Diabetes Res"},{"issue":"12","key":"10.1016\/j.dsx.2026.103374_bib21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/BF00400603","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study)","volume":"38","author":"Ziegler","year":"1995","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.dsx.2026.103374_bib22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2337\/diacare.22.8.1296","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). ALADIN III study group. alpha-Lipoic acid in diabetic neuropathy","volume":"22","author":"Ziegler","year":"1999","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.dsx.2026.103374_bib23","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.dsx.2026.103374_bib24","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dc11-0503","article-title":"Efficacy and safety of antioxidant treatment with \u03b1-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial","volume":"34","author":"Ziegler","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2026.103374_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4093\/dmj.2019.0099","article-title":"\u03b3-Linolenic acid versus \u03b1-Lipoic acid for treating painful diabetic neuropathy in adults: a 12-Week, double-Placebo, randomized, noninferiority trial","volume":"44","author":"Won","year":"2020","journal-title":"Diabetes Metab J"},{"issue":"3","key":"10.1016\/j.dsx.2026.103374_bib26","first-page":"621","article-title":"Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy","volume":"37","author":"Cheng","year":"2024","journal-title":"Pak J Pharm Sci"},{"issue":"3","key":"10.1016\/j.dsx.2026.103374_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2000-7739","article-title":"Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy","volume":"108","author":"Haak","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"10.1016\/j.dsx.2026.103374_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1568026615666150114161358","article-title":"Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications","volume":"15","author":"Moura","year":"2015","journal-title":"Curr Top Med Chem"},{"issue":"44","key":"10.1016\/j.dsx.2026.103374_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035368","article-title":"Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: a systematic review and meta-analysis","volume":"102","author":"Orellana-Donoso","year":"2023","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.dsx.2026.103374_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcjd.2024.01.007","article-title":"Ranking alpha lipoic acid and gamma linolenic acid in terms of efficacy and safety in the management of adults with diabetic peripheral neuropathy: a systematic review and network meta-analysis","volume":"48","author":"Prado","year":"2024","journal-title":"Can J Diabetes"},{"issue":"2","key":"10.1016\/j.dsx.2026.103374_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1464-5491.2004.01109.x","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis","volume":"21","author":"Ziegler","year":"2004","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.dsx.2026.103374_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2362.2009.02236.x","article-title":"Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial","volume":"40","author":"Heinisch","year":"2010","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1016\/j.dsx.2026.103374_bib33","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1080\/10408398.2020.1861425","article-title":"Role of alpha-lipoic acid in vascular function: a systematic review of human intervention studies","volume":"62","author":"Hajizadeh-Sharafabad","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.dsx.2026.103374_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116417","article-title":"Painful diabetic neuropathy: the role of ion channels","volume":"173","author":"Wang","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.dsx.2026.103374_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5483\/BMBRep.2019.52.10.026","article-title":"Effects of \u03b1-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation","volume":"52","author":"Kim","year":"2019","journal-title":"BMB Rep"},{"issue":"3","key":"10.1016\/j.dsx.2026.103374_bib36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2005.05.035","article-title":"Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle","volume":"332","author":"Lee","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.dsx.2026.103374_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3164\/jcbn.2008051","article-title":"Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis","volume":"43","author":"Amom","year":"2008","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.dsx.2026.103374_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2011.00069","article-title":"Diabetes and alpha lipoic acid","volume":"2","author":"Golbidi","year":"2011","journal-title":"Front Pharmacol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:16:20Z","timestamp":1773317780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402126000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1871402126000019"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103374","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of alpha lipoic acid supplementation on biochemical, clinical, and inflammatory parameters in patients with diabetic polyneuropathy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC).","name":"copyright","label":"Copyright"}],"article-number":"103374"}}